NeurAxis (NRXS) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free NRXS Stock Alerts $2.76 -0.06 (-2.13%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 4:30 PM | globenewswire.comNeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024May 12 at 1:50 AM | americanbankingnews.comNeurAxis (NRXS) versus Its Peers Critical ReviewMay 8, 2024 | americanbankingnews.comHead-To-Head Analysis: NeurAxis (NRXS) & Its PeersMay 6, 2024 | americanbankingnews.comFinancial Contrast: NeurAxis (NRXS) and The CompetitionApril 23, 2024 | globenewswire.comNeurAxis Announces New Medical Policy Coverage in North DakotaApril 12, 2024 | finance.yahoo.comNeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call TranscriptApril 11, 2024 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsApril 11, 2024 | seekingalpha.comNeurAxis, Inc. (NRXS) Q4 2023 Earnings Call TranscriptApril 9, 2024 | globenewswire.comNeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsApril 1, 2024 | globenewswire.comNeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024March 27, 2024 | globenewswire.comNeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center RegistryMarch 11, 2024 | globenewswire.comNeurAxis Announces Highmark BCBS Policy CoverageMarch 4, 2024 | globenewswire.comNeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy CoverageFebruary 27, 2024 | globenewswire.comNeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceFebruary 1, 2024 | au.finance.yahoo.comNeurAxis, Inc. (NRXS)January 31, 2024 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Appoints Timothy Henrichs as Chief Financial OfficerJanuary 31, 2024 | finance.yahoo.comNeurAxis Appoints Timothy Henrichs as Chief Financial OfficerDecember 20, 2023 | finanznachrichten.deNeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerDecember 20, 2023 | finance.yahoo.comNeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerNovember 21, 2023 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Reports Third Quarter 2023 Financial ResultsNovember 21, 2023 | msn.comNeurAxis reports Q3 resultsNovember 20, 2023 | finance.yahoo.comNeurAxis Reports Third Quarter 2023 Financial ResultsNovember 15, 2023 | finance.yahoo.comNeurAxis Announces CareFirst BCBS Policy CoverageNovember 14, 2023 | msn.comNeurAxis secures $3M financing through preferred stock offeringNovember 14, 2023 | finance.yahoo.comNeurAxis Secures $3 Million FinancingNovember 8, 2023 | finance.yahoo.comNeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal DeviceNovember 5, 2023 | morningstar.comNeuraxis Inc NRXS Stock QuoteSeptember 26, 2023 | finance.yahoo.comNeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain DisordersSeptember 21, 2023 | finance.yahoo.comNeurAxis Reports Second Quarter 2023 Financial ResultsSeptember 13, 2023 | finance.yahoo.comNeurAxis to Present at the Gilmartin Group Emerging Growth ShowcaseSeptember 12, 2023 | stockhouse.comNeurAxis Announces Publication of Prospective Study Showing IB-Stim(TM) Improves Quality of Life of Adolescents with IBSSeptember 12, 2023 | msn.comEXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel SyndromeSeptember 12, 2023 | finance.yahoo.comNeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBSSeptember 8, 2023 | finance.yahoo.comNeurAxis Highlights Current Commercial Insurance Coverage with BCBS Massachusetts, BCBS South Carolina, BCBS Nebraska, and Quartz WisconsinSeptember 8, 2023 | finance.yahoo.comExchange Listing Client, Neuraxis, Inc., Successfully Completes Its Initial Public Offering and NYSE ListingSeptember 8, 2023 | finance.yahoo.comGoldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.September 8, 2023 | finance.yahoo.comNeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023September 8, 2023 | finance.yahoo.comNeurAxis Announces Over $8 Million in IB-Stim™ RevenueSeptember 8, 2023 | finance.yahoo.comNeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut MicrobiomeSeptember 8, 2023 | finance.yahoo.comNeurAxis Highlights Strength of its Board of DirectorsSeptember 8, 2023 | finance.yahoo.comNeurAxis Highlights Pediatric Post-Concussion Clinical Study Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history. Watch his stock warning right here, 100% free of charge NRXS Media Mentions By Week NRXS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXS News Sentiment▼-0.360.55▲Average Medical News Sentiment NRXS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXS Articles This Week▼21▲NRXS Articles Average Week Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BioSig Technologies News QT Imaging News Precision Optics News Pixie Dust Technologies News electroCore News Movano News Hyperfine News Agape ATP News Synlogic News Onconova Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXS) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
